| Product Name | MF | CAS | Details |
|---|
| Fmoc-VAP-MMAE | C70H98N8O13 | 1912408-91-3 | Details |
| DDO-2213 | 2378768-36-4 | Details |
| Anticancer agent 86 | 2841406-04-8 | Details |
| Antifungal agent 77 | 2863678-89-9 | Details |
| Elisidepsin | C75H124N14O16 | 681272-30-0 | Details |
| Antitumor agent-67 | 2820146-10-7 | Details |
| Glucocorticoid receptor agonist-1 phosphate Gly-Glu TFA | 2734877-83-7 | Details |
| AtPCO4-IN-1 | C24H30O6 | 316134-38-0 | Details |
| AP-C3 | 682795-78-4 | Details |
| Fluorescein octadecyl ester | C38H48O5 | 138833-46-2 | Details |
| DYSP-C34 | C45H47N5O10 | 2559734-98-2 | Details |
| Epigenetic factor-IN-1 | C32H34FN5O6S2 | 2640673-56-7 | Details |
| Hydroxydione | C21H32O3 | 303-01-5 | Details |
| DHFR-IN-10 | 929484-47-9 | Details |
| Gly-Mal-Gly-Gly-Phe-Gly-amide-methylcyclopropane-Exatecan | 2766786-76-7 | Details |
| HCAR2 agonist 1 | C26H28N4O2 | 1066676-21-8 | Details |
| Antitumor agent-40 | C30H54NaO77PS16 | 2096500-09-1 | Details |
| Anticancer agent 131 | 2864443-47-8 | Details |
| Bcl-2-IN-12 | 1383737-59-4 | Details |
| CDK9-IN-29 | 2737262-24-5 | Details |
| ICMT-IN-1 | 1313603-22-3 | Details |
| Cy-FBP/SBPase-IN-1 | C18H14Cl2N4O2S3 | 444792-16-9 | Details |
| AP-C7 | 2234275-84-2 | Details |
| BCR-ABL-IN-8 | 1808288-49-4 | Details |
| ATAC21 | 2101204-23-1 | Details |
| DosatiLink-1 | 2941512-37-2 | Details |
| Bcl-2-IN-13 | 1421687-31-1 | Details |
| IA1-8H2 | 2755685-19-7 | Details |
| AP-C6 | C15H15N5O | 2234276-60-7 | Details |
| Anti-hepatic fibrosis agent 2 | 2380421-60-1 | Details |
| Antitumor photosensitizer-1 | 2344751-89-7 | Details |
| BX-2819 | 1184181-50-7 | Details |
| GABA-IN-2 | 2363715-13-1 | Details |
| E104 | 1610431-21-4 | Details |
| Dibutepinephrine | C17H25NO5 | 2735735-23-4 | Details |
| Biotin-hexanamide-(L-Thyroxine) | 2278192-78-0 | Details |
| Anticancer agent 168 | C16H11ClN2O6 | 207399-56-2 | Details |
| Antiproliferative agent-39 | C22H22N4O3 | 871837-61-5 | Details |
| CD33 splicing modulator 1 hydrochloride | C25H25FN6O.ClH | 2762547-06-6 | Details |
| CDFI | 1199797-92-6 | Details |
| Antitumor agent-29 | 2847856-44-2 | Details |
| Antiproliferative agent-40 | C20H18N4O3 | 871837-59-1 | Details |
| D359-0396 | C24H24N4O2 | 1031977-31-7 | Details |
| D1N8 | 2894770-40-0 | Details |
| CL2E-SN38 | C87H116N14O24 | 1639139-65-3 | Details |
| FOXM1-IN-2 | 2694866-10-7 | Details |
| FAAH/cPLA2α-IN-1 | 1696401-38-3 | Details |
| Biotin-PEG3-amide-C2-CO-Halofuginone | 2758563-75-4 | Details |
| Antitumor agent-49 | 2763914-21-0 | Details |
| Anticancer agent 113 | C27H31ClN6O2 | 2495323-17-4 | Details |
| Bemfivastatin hemicalcium | C34 H37 F N2 O6 . 1/2 Ca | 805241-64-9 | Details |
| HDAC1/CDK7-IN-1 | 2987905-95-1 | Details |
| HCoV-OC43-IN-1 | 2809363-81-1 | Details |
| GGFG-Eribulin | 2841688-66-0 | Details |
| GEM–IB | 2866211-93-8 | Details |
| DosatiLink-2 | 2941512-38-3 | Details |
| GSPT1 degrader-2 | C22H20ClN3O5 | 2803879-60-7 | Details |
| Cyclohexyl [3,5-bis(methylthio)-4-isothiazolyl]carbamate | 311334-13-1 | Details |
| Anticancer agent 162 | 2761736-66-5 | Details |
| Antiproliferative agent-37 | C21H17FN2O2 | 2989275-31-0 | Details |
| Antiviral agent 27 | C24H34N2O | 2270947-36-7 | Details |
| Cholesterol 24-hydroxylase-IN-2 | C20H23FN4O | 1613481-52-9 | Details |
| ATUX-1215 | 2910929-53-0 | Details |
| APS3 | 1225373-70-5 | Details |
| ASC-69 | C19H19N7 | 1216665-50-7 | Details |
| FGFR3-IN-7 | 2833703-79-8 | Details |
| Estrogen receptor modulator 10 | 2991504-90-4 | Details |
| Bcl-2-IN-16 | 2858632-01-4 | Details |
| BChE-IN-20 | 1428439-79-5 | Details |
| ASN 07115873 | 626220-97-1 | Details |
| Anti-MI/R injury agent 1 | C32H49NO6 | 2387506-35-4 | Details |
| AP-C4 | 682794-85-0 | Details |
| FPR2 agonist 3 | 2829263-19-4 | Details |
| Civorebrutinib | C23H22ClN7O2 | 2155853-43-1 | Details |
| GPR3 agonist-2 | 1983120-51-9 | Details |
| Dual photoCORM 1 | 2892235-55-9 | Details |
| Antiproliferative agent-38 | C15H10N2 | 239-13-4 | Details |
| FGFR3-IN-6 | 2833703-72-1 | Details |
| Bexicaserin | 2035818-24-5 | Details |
| Anticancer agent 112 | C27H32ClN7O | 2495321-37-2 | Details |
| DL-01 | C55H71N9O13S | 2821770-49-2 | Details |
| Antitumor agent-120 | C17H16N2O3 | 948901-10-8 | Details |
| F1874-108 | C15H14N4O2S | 335223-43-3 | Details |
| Human enteropeptidase-IN-3 | 1958037-36-9 | Details |
| HDAC6-IN-21 | 2920929-76-4 | Details |
| Elastase LasB-IN-1 | 2762675-17-0 | Details |
| DQP-997-74 | 2377187-09-0 | Details |
| CcpA-IN-1 | 2702277-62-9 | Details |
| CCG-232964 | C15H15ClN2O3S | 2349373-70-0 | Details |
| AP-C1 | 2234280-26-1 | Details |
| D1N52 | 2894770-48-8 | Details |
| Anticancer agent 95 | C30H32ClN5O3 | 853302-91-7 | Details |
| cis-Indatraline hydrochloride | C16H15Cl2N.ClH | 86939-08-4 | Details |
| Anticancer agent 166 | C19H14OS | 6630-80-4 | Details |
| CU06-1004 | 1296734-08-1 | Details |
| Free radical scavenger 1 | 2989970-81-0 | Details |
| GPR139 agonist-2 | 2983118-29-0 | Details |
| Antitumor photosensitizer-2 | C40H47N5O7 | 2344751-92-2 | Details |
| Product Total： Product Page： | ||||
| 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 | ||||